Mural Oncology plc
MURA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $43 | $22 | $55 |
| - Cash | $59 | $77 | $107 | $115 |
| + Debt | $0 | $5 | $7 | $8 |
| Enterprise Value | – | -$29 | -$78 | -$52 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$1 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3 | -$47 | -$34 | -$35 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$48 | -$33 | -$34 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.21 | -2.78 | -1.93 | -2.01 |
| % Growth | 92.4% | -44% | 4% | – |
| Operating Cash Flow | -$18 | -$31 | -$37 | -$32 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$18 | -$31 | -$37 | -$32 |